Skip to search formSkip to main contentSkip to account menu

Malignant Mesothelioma of Peritoneum

Known as: mesothelioma of peritoneum, mesothelioma peritoneum, Peritoneal mesothelioma 
An aggressive malignant mesothelioma that arises from the peritoneum. Patients usually present with abdominal pain and ascites.
National Institutes of Health

Related topics

Related topics

12 relations
Abdominal CavityAbdominal PainCDKN2A geneMesothelial cell

Broader (3)

Malignant mesotheliomaPeritoneal Mesotheliomaperitoneal cavity cancer

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study.
Review
2015
Review
2015
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: A Systematic Review and Meta-analysis
AbstractBackgroundDue to the increased adoption of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy… 
Highly Cited
2009
Highly Cited
2009
Predicting survival in malignant mesothelioma
Malignant mesothelioma (MM) of the pleura or peritoneum is a universally fatal disease attracting an increasing range of medical… 
Highly Cited
2009
Highly Cited
2009
Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005
We analyzed mesothelioma incidence in the Surveillance, Epidemiology, and End Results (SEER) database over the period 1973–2005… 
Highly Cited
2008
Highly Cited
2008
Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas
Definitive diagnosis of malignant mesothelioma in small specimens can be extremely difficult based on morphology alone… 
Review
2007
Review
2007
A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma
ABSTRACT Background: In the past, diffuse malignant peritoneal mesothelioma (DMPM) was regarded as a preterminal condition. The… 
Highly Cited
2006
Highly Cited
2006
Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian Cancer
Purpose: To determine whether mesothelin, a cell surface protein highly expressed in mesothelioma and ovarian cancer, is shed… 
Highly Cited
2005
Highly Cited
2005
Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.
BACKGROUND To date, few large studies have been reported of patients with peritoneal mesothelioma, and treatment of this disease… 
Review
2003
Review
2003
Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.
PURPOSE Malignant mesothelioma (MM) arising in the peritoneal cavity is a rare neoplasm characterized by peritoneal progression… 
Highly Cited
2002
Highly Cited
2002
Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Cases
Cytokeratin 5/6 (CK 5/6) immunoreactivity has been observed in the vast majority of cases of malignant mesothelioma but only… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)